TELOCEL Trademark

Trademark Overview


On Wednesday, December 22, 2021, a trademark application was filed for TELOCEL with the United States Patent and Trademark Office. The USPTO has given the TELOCEL trademark a serial number of 97185885. The federal status of this trademark filing is REGISTERED as of Tuesday, August 8, 2023. This trademark is owned by Seragon Pharmaceuticals Inc.. The TELOCEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for immunotherapy, including cell therapy and gene therapy; pharmaceutical and biological preparations for medical diagnostic use; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the nervous system, the immune system and the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for medical use, namely, for use in dermatology, oncology, hematology and in tissue and organ transplantation in ophthalmology and for gastroenterological diseases and disorders
telocel

General Information


Serial Number97185885
Word MarkTELOCEL
Filing DateWednesday, December 22, 2021
Status700 - REGISTERED
Status DateTuesday, August 8, 2023
Registration Number7129731
Registration DateTuesday, August 8, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 23, 2023

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for immunotherapy, including cell therapy and gene therapy; pharmaceutical and biological preparations for medical diagnostic use; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the nervous system, the immune system and the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for medical use, namely, for use in dermatology, oncology, hematology and in tissue and organ transplantation in ophthalmology and for gastroenterological diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 29, 2021
Primary Code005
First Use Anywhere DateTuesday, June 22, 2021
First Use In Commerce DateTuesday, June 22, 2021

Trademark Owner History


Party NameSeragon Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Party NameSeragon Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Party NameSeragon Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events


Event DateEvent Description
Tuesday, August 8, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 8, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 23, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 3, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 18, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, April 18, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 18, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, April 18, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 4, 2022NON-FINAL ACTION E-MAILED
Tuesday, October 4, 2022NON-FINAL ACTION WRITTEN
Monday, September 26, 2022ASSIGNED TO EXAMINER
Wednesday, December 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 25, 2021NEW APPLICATION ENTERED